GDFN yields 8.31% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 6
Combined, GDFN + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GDFN + MRK for your $10,000?
GDFN focuses on companies within the aerospace and defense sector, investing in pure-play stocks from defense-related activities and prioritizing innovation. Investments center in three key sub-sectors: defense equipment (robotics, drones, military vehicles, space tech, sensor and networking systems, and advanced weaponry), defense technology (AI, IoT, AR/VR, big data analytics, geospatial intelligence, security scanning solutions), and cyber defense firms protecting critical infrastructure. The fund primarily holds between 15 to 100 companies outside the US and Canada, with up to 25% in emerging markets. Security selection combines top-down sector and bottom-up fundamental and valuation analysis to identify attractively valued companies with strong growth prospects. The fund does not hedge currency risk. The fund may engage in security lending. As an actively managed fund, the adviser continuously monitors and adjusts the portfolio based on market and company developments.
Full GDFN Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.